Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by Insightful1on Aug 10, 2020 12:20am
199 Views
Post# 31385743

RE:RE:My position on MedX is its differentiation

RE:RE:My position on MedX is its differentiation I am sorry you have owned this stock this long, it would explain your frustration. I am interested in where you get the idea there will be no revenue until late 2021?? That seems like an odd statement. The new management team has given guidance for 2020 Q3-Q4 so I would expect that to be accurate. Brazil is receiving units and I would expect that revenue to start showing up in Q3 and then Mexico will come online. I expect MedX has been very active both here and the USA so I would think you estimates are way off. As for Spain, the trial is on hold as I understand until things normalize I am sure it will come back online as soon as the COVID settles down and testing can resume. 

Unfortunately new investors don't care that you have been here for over a decade. You are upset more at yourself for hanging around this long is my guess. Remember the new investors are Institutional and have a much different operational undrstanding than the average retail investor. They have just invested ~$ 4million in MedX maybe they see this opportuniy with fresh eyes.

If the new management team did not step in 6 years ago  you wouldn't have had any chance of getting your money back because MedX was done. They stepped in at $.04 or about a $3.2 million market cap so maybe they do know what they are doing.

Time will tell.
Bullboard Posts